P10 INC-A (PX) Fundamental Analysis & Valuation

NYSE:PX • US69376K1060

Current stock price

10.54 USD
+0.09 (+0.86%)
At close:
10.54 USD
0 (0%)
After Hours:

This PX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. PX Profitability Analysis

1.1 Basic Checks

  • PX had positive earnings in the past year.
  • In the past year PX had a positive cash flow from operations.
  • PX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years PX had a positive operating cash flow.
PX Yearly Net Income VS EBIT VS OCF VS FCFPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

  • PX has a worse Return On Assets (1.64%) than 62.45% of its industry peers.
  • PX has a worse Return On Equity (4.45%) than 63.29% of its industry peers.
  • PX's Return On Invested Capital of 5.14% is fine compared to the rest of the industry. PX outperforms 67.09% of its industry peers.
  • PX had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 7.06%.
  • The 3 year average ROIC (3.89%) for PX is below the current ROIC(5.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.64%
ROE 4.45%
ROIC 5.14%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
PX Yearly ROA, ROE, ROICPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.09%, PX is doing worse than 72.57% of the companies in the same industry.
  • PX's Profit Margin has declined in the last couple of years.
  • PX has a Operating Margin (20.75%) which is comparable to the rest of the industry.
  • PX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.75%
PM (TTM) 5.09%
GM N/A
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
PX Yearly Profit, Operating, Gross MarginsPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PX has less shares outstanding
  • PX has more shares outstanding than it did 5 years ago.
  • PX has a worse debt/assets ratio than last year.
PX Yearly Shares OutstandingPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PX Yearly Total Debt VS Total AssetsPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • PX has an Altman-Z score of 1.41. This is a bad value and indicates that PX is not financially healthy and even has some risk of bankruptcy.
  • PX has a Altman-Z score of 1.41. This is in the better half of the industry: PX outperforms 64.98% of its industry peers.
  • PX has a debt to FCF ratio of 17.48. This is a negative value and a sign of low solvency as PX would need 17.48 years to pay back of all of its debts.
  • PX has a Debt to FCF ratio (17.48) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.14 is on the high side and indicates that PX has dependencies on debt financing.
  • PX has a Debt to Equity ratio of 1.14. This is comparable to the rest of the industry: PX outperforms 43.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.49
Altman-Z 1.41
ROIC/WACCN/A
WACCN/A
PX Yearly LT Debt VS Equity VS FCFPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • PX has a Current Ratio of 0.98. This is a bad value and indicates that PX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PX has a Current ratio (0.98) which is in line with its industry peers.
  • A Quick Ratio of 0.98 indicates that PX may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.98, PX is in line with its industry, outperforming 43.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
PX Yearly Current Assets VS Current LiabilitesPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PX Growth Analysis

3.1 Past

  • PX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.43%.
  • PX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.62% yearly.
  • Looking at the last year, PX shows a quite strong growth in Revenue. The Revenue has grown by 9.77% in the last year.
  • The Revenue has been growing by 45.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)5.43%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-7.69%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.72% on average over the next years. This is quite good.
  • PX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.06% yearly.
EPS Next Y-7.96%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y10.02%
Revenue Next 3Y11.06%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PX Yearly Revenue VS EstimatesPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
PX Yearly EPS VS EstimatesPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. PX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.87, the valuation of PX can be described as reasonable.
  • Based on the Price/Earnings ratio, PX is valued a bit cheaper than 63.29% of the companies in the same industry.
  • PX is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 9.39 indicates a reasonable valuation of PX.
  • Based on the Price/Forward Earnings ratio, PX is valued a bit cheaper than 75.95% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. PX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.87
Fwd PE 9.39
PX Price Earnings VS Forward Price EarningsPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PX is valued a bit cheaper than 75.53% of the companies in the same industry.
  • PX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.49
EV/EBITDA 17.17
PX Per share dataPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3
EPS Next 2Y5.44%
EPS Next 3Y8.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. PX Dividend Analysis

5.1 Amount

  • PX has a Yearly Dividend Yield of 1.39%.
  • Compared to an average industry Dividend Yield of 6.65, PX is paying slightly less dividend.
  • Compared to the average S&P500 Dividend Yield of 1.82, PX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

  • PX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • PX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
PX Yearly Dividends per sharePX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • PX pays out 105.06% of its income as dividend. This is not a sustainable payout ratio.
DP105.06%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
PX Yearly Income VS Free CF VS DividendPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
PX Dividend Payout.PX Dividend Payout, showing the Payout Ratio.PX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PX Fundamentals: All Metrics, Ratios and Statistics

P10 INC-A

NYSE:PX (2/10/2026, 8:04:00 PM)

After market: 10.54 0 (0%)

10.54

+0.09 (+0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners68.65%
Inst Owner Change0.03%
Ins Owners20.61%
Ins Owner Change0.22%
Market Cap1.16B
Revenue(TTM)301.31M
Net Income(TTM)15.33M
Analysts81.54
Price Target16.96 (60.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP105.06%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.18%
Min EPS beat(2)0.22%
Max EPS beat(2)10.14%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-5.74%
Max EPS beat(4)11.29%
EPS beat(8)6
Avg EPS beat(8)8.11%
EPS beat(12)10
Avg EPS beat(12)7.97%
EPS beat(16)14
Avg EPS beat(16)7.09%
Revenue beat(2)0
Avg Revenue beat(2)-3%
Min Revenue beat(2)-5.07%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)11.75%
Revenue beat(8)4
Avg Revenue beat(8)1.36%
Revenue beat(12)7
Avg Revenue beat(12)2.14%
Revenue beat(16)10
Avg Revenue beat(16)1.82%
PT rev (1m)4.72%
PT rev (3m)10.83%
EPS NQ rev (1m)1.26%
EPS NQ rev (3m)-1.23%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.63%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-1.32%
Valuation
Industry RankSector Rank
PE 10.87
Fwd PE 9.39
P/S 3.84
P/FCF 51.49
P/OCF 41.72
P/B 3.36
P/tB N/A
EV/EBITDA 17.17
EPS(TTM)0.97
EY9.2%
EPS(NY)1.12
Fwd EY10.65%
FCF(TTM)0.2
FCFY1.94%
OCF(TTM)0.25
OCFY2.4%
SpS2.74
BVpS3.14
TBVpS-2.98
PEG (NY)N/A
PEG (5Y)3
Graham Number8.27
Profitability
Industry RankSector Rank
ROA 1.64%
ROE 4.45%
ROCE 7.41%
ROIC 5.14%
ROICexc 5.39%
ROICexgc 32.93%
OM 20.75%
PM (TTM) 5.09%
GM N/A
FCFM 7.47%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
ROICexc(3y)4.15%
ROICexc(5y)3.64%
ROICexgc(3y)42.32%
ROICexgc(5y)39%
ROCE(3y)5.62%
ROCE(5y)4.93%
ROICexgc growth 3Y14.25%
ROICexgc growth 5Y7.5%
ROICexc growth 3Y11.21%
ROICexc growth 5Y3.97%
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.49
Debt/EBITDA 4.47
Cap/Depr 20.64%
Cap/Sales 1.75%
Interest Coverage 2.41
Cash Conversion 31.54%
Profit Quality 146.76%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.41
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.31%
Cap/Depr(5y)5.71%
Cap/Sales(3y)0.97%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.43%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-7.69%
EPS Next Y-7.96%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.27%
Revenue Next Year2.39%
Revenue Next 2Y10.02%
Revenue Next 3Y11.06%
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3Y14.58%
EBIT growth 5Y36.48%
EBIT Next Year-22.1%
EBIT Next 3Y-5.84%
EBIT Next 5YN/A
FCF growth 1Y-63.8%
FCF growth 3Y25.32%
FCF growth 5Y41.79%
OCF growth 1Y-56.3%
OCF growth 3Y27.23%
OCF growth 5Y43.11%

P10 INC-A / PX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of P10 INC-A (PX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PX.


What is the valuation status of P10 INC-A (PX) stock?

ChartMill assigns a valuation rating of 5 / 10 to P10 INC-A (PX). This can be considered as Fairly Valued.


How profitable is P10 INC-A (PX) stock?

P10 INC-A (PX) has a profitability rating of 3 / 10.


How financially healthy is P10 INC-A?

The financial health rating of P10 INC-A (PX) is 2 / 10.


Can you provide the expected EPS growth for PX stock?

The Earnings per Share (EPS) of P10 INC-A (PX) is expected to decline by -7.96% in the next year.